Juret P, Couette J E, Delozier T, Leplat G, Mandard A M, Vernhes J C
Lancet. 1978 Feb 25;1(8061):415-7. doi: 10.1016/s0140-6736(78)91204-7.
The sex of the first child of patients who underwent mastectomy for potentially curable breast cancer appeared to be a valuable prognostic factor: patients whose first child was a boy had a better outcome than those whose first child was a girl. The difference was statistically significant. This may have been because the male/female sex ratio among first children was significantly higher in those patients without node involvement than in those with node involvement. But the favourable effect of a male first birth was still seen when only patients with an equal degree of node involvement (greater than or equal to 4 nodes) were studied. The "protection" resulting from a male first-born could be the result of fetal testicular secretions. This protection did not apply to the risk of breast cancer--the male/female sex ratio of first children in our series was 1.08, a figure not statistically different from that of the overall French population (1.05).
头胎为男孩的患者比头胎为女孩的患者预后更好。这种差异具有统计学意义。这可能是因为无淋巴结受累患者的头胎男女比例显著高于有淋巴结受累患者。但在仅研究淋巴结受累程度相同(大于或等于4个淋巴结)的患者时,头胎为男性的有利影响仍然可见。头胎为男性所带来的“保护”可能是胎儿睾丸分泌的结果。这种保护不适用于患乳腺癌的风险——我们研究系列中的头胎男女比例为1.08,与法国总体人群的比例(1.05)在统计学上无差异。